Abstract

This report surveys the commercial in vitro plant production in Germany from 1985–2004. From twelve commercial tissue culture laboratories starting in 1984, the number increased to 27–30 companies in Germany at the present time. Eight out of them produced more than one million plants per year, and altogether these eight companies account for 92% of total production. Smaller laboratories cloning pathogen-free stock plants for traditional vegetative propagation or breeding purposes are often associated with plant breeding companies or nurseries. Between 1985 and 1992, the total production increased from 5 to nearly 20 million plants per year. Followed by five years of stagnation, in the last seven years (1998–2004) a drastic rise in total production to more than 48 million plants in 2004 was recorded. This steep increase was entirely due to the increasing in vitro production of Phalaenopsis, which now occupies the leading position in flowering pot plants in the Netherlands (Anonymous 2003, Vakblad voor de Bloemisterij 21a: 136). In 2004, German in vitro laboratories produced more than 31 million plants of this orchid. Other important plant genera are Fragaria (3.9 million), Rhododendron (1.0 million), and Gentiana (1.9 million). Plant groups of increasing importance are aquarium plants and garden perennials.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.